Urban Innovation Fund

Urban Innovation Fund is a San Francisco seed firm that backs companies solving challenges of urban life, including public health, civic infrastructure, mobility, education, and the future of work. Healthcare appears through the public-health and digital-health lens rather than as a clinical-pharma practice, which is the right framing for founders pitching here.

The stated thesis centers on cities as both the site and the customer of innovation, with a particular interest in companies that intersect with regulated environments. For digital health founders, that translates to community health, population health, behavioral health adjacent to social determinants, and tools that public agencies or large employers might procure. The fund leans toward companies whose growth depends on navigating regulation, public procurement, or civic infrastructure rather than purely consumer or enterprise SaaS dynamics. Specific portfolio companies are not provided in the source record, so founders should review the firm’s site to identify the closest analogues before reaching out.

Urban Innovation Fund invests at pre-seed and seed, with disclosed checks in the $1M to $5M band and an actual deployment range typically falling between $500K and $3M. They have a track record of leading or co-leading rounds rather than only participating, which makes them useful as an anchor for first institutional capital. Geographic focus is United States only, with a clear San Francisco and West Coast center of gravity though they invest nationally.

The team page is the right reference point for partner identification; named partners are not provided in the input record, so founders should confirm coverage before reaching out.

Approach Urban Innovation Fund when your digital health company touches public-sector buyers, Medicaid populations, social determinants, or civic infrastructure, and when a roughly $1M to $3M seed lead is the right shape of capital. They are not the right call for purely commercial, payer-direct, or pharma-services plays. A warm intro through a portfolio founder is the strongest entry; the website application form is the documented alternative. Bring evidence of regulatory awareness, a clear procurement pathway, and the specific city or agency relationships you have already opened, because that is the lens through which the firm evaluates traction. Founders raising larger growth rounds should keep them in the syndicate conversation but seek a stage-specialist lead.